Amgen Inc (NASDAQ:AMGN)
| 232.68 BATS BZX Real-Time Price As of 1:30pm ET |  +2.86 / +1.24%Today’s Change | 223.30 Today|||52-Week Range 296.67 | -11.41% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 229.82 |
| Today’s open | 230.03 |
| Day’s range | 229.91 - 234.02 |
| Volume | 47,741 |
| Average volume (3 months) | 2,623,209 |
| Market cap | $125.3B |
Data as of 1:30pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | +17.80% |
| Earnings growth (this year) | +1.49% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +0.40% |
| P/E ratio | 19.2 |
| Price/Sales | 5.45 |
| Price/Book | 34.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | +0.75 | +0.96% |
| ---- | ||
| MRNAModerna Inc | +0.14 | +0.09% |
| BIIBBiogen | +2.58 | +0.99% |
Data as of 1:30pm ET, 03/23/2023
Financials
| Next reporting date | April 25, 2023 |
| EPS forecast (this quarter) | $4.00 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $6.6B |
| Net profit margin | 25.11% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
